Literature DB >> 15164181

Specific monoclonal antibody-based immunotherapy by targeting the RCC-associated antigen carbonic anhydrase-IX(G250/MN).

Peter Mulders1, I Bleumer, F Debruyne, E Oosterwijk.   

Abstract

Mesh:

Substances:

Year:  2004        PMID: 15164181     DOI: 10.1007/s00120-004-0609-3

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


× No keyword cloud information.
  4 in total

1.  Monoclonal antibody G 250 recognizes a determinant present in renal-cell carcinoma and absent from normal kidney.

Authors:  E Oosterwijk; D J Ruiter; P J Hoedemaeker; E K Pauwels; U Jonas; J Zwartendijk; S O Warnaar
Journal:  Int J Cancer       Date:  1986-10-15       Impact factor: 7.396

2.  Phase I radioimmunotherapy of metastatic renal cell carcinoma with 131I-labeled chimeric monoclonal antibody G250.

Authors:  M G Steffens; O C Boerman; P H de Mulder; W J Oyen; W C Buijs; J A Witjes; W J van den Broek; J C Oosterwijk-Wakka; F M Debruyne; F H Corstens; E Oosterwijk
Journal:  Clin Cancer Res       Date:  1999-10       Impact factor: 12.531

3.  Anti-renal cell carcinoma chimeric antibody G250: cytokine enhancement of in vitro antibody-dependent cellular cytotoxicity.

Authors:  Zhanqi Liu; Fiona E Smyth; Christoph Renner; Fook-Thean Lee; Egbert Oosterwijk; Andrew M Scott
Journal:  Cancer Immunol Immunother       Date:  2002-03-01       Impact factor: 6.968

Review 4.  Immunotherapy for renal cell carcinoma.

Authors:  Ivar Bleumer; Egbert Oosterwijk; Pieter De Mulder; Peter F A Mulders
Journal:  Eur Urol       Date:  2003-07       Impact factor: 20.096

  4 in total
  5 in total

1.  Overexpression of carbonic anhydrase IX (CAIX) in vulvar cancer is associated with tumor progression and development of locoregional lymph node metastases.

Authors:  Matthias Choschzick; Linn Woelber; Stephan Hess; Christine zu Eulenburg; Jörg Schwarz; Ronald Simon; Sven Mahner; Fritz Jaenicke; Volkmar Müller
Journal:  Virchows Arch       Date:  2010-04-01       Impact factor: 4.064

2.  Overexpression of carbonic anhydrase IX (CAIX) is an independent unfavorable prognostic marker in endometrioid ovarian cancer.

Authors:  Matthias Choschzick; Egbert Oosterwijk; Volkmar Müller; Linn Woelber; Ronald Simon; Holger Moch; Pierre Tennstedt
Journal:  Virchows Arch       Date:  2011-06-21       Impact factor: 4.064

3.  Advances in Anti-Cancer Drug Development Targeting Carbonic Anhydrase IX and XII.

Authors:  Mam Y Mboge; Robert McKenna; Susan C Frost
Journal:  Top Anticancer Res       Date:  2015

Review 4.  Carbonic Anhydrases: Role in pH Control and Cancer.

Authors:  Mam Y Mboge; Brian P Mahon; Robert McKenna; Susan C Frost
Journal:  Metabolites       Date:  2018-02-28

Review 5.  Biophysical, Biochemical, and Cell Based Approaches Used to Decipher the Role of Carbonic Anhydrases in Cancer and to Evaluate the Potency of Targeted Inhibitors.

Authors:  Mam Y Mboge; Anusha Kota; Robert McKenna; Susan C Frost
Journal:  Int J Med Chem       Date:  2018-07-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.